SCHEMBL21801581

SCHEMBL21801581

CCOC(=O)c1c(-c2c(CO[Si](C)(C)C(C)(C)C)n(C(C)C)c3ncnc(NCc4ccc(OC)cc4OC)c23)noc1C1CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.40
▸ CYP1A2 P05177 7/20 0.38
▸ CYP3A4 P08684 7/20 0.38
▸ CYP2C19 P33261 7/20 0.38
▸ ALDH1A1 P00352 6/20 0.36
▸ USP2 O75604 5/20 0.36
▸ CYP2D6 P10635 5/20 0.36
▸ MAPK1 P28482 5/20 0.36
▸ CLK4 Q9HAZ1 4/20 0.36
▸ LMNA P02545 3/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ SLC26A6 Q9BXS9 1/20 0.35
▸ HSD17B10 Q99714 3/20 0.32
▸ RET P07949 1/20 0.32
▸ RORC P51449 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ TSHR P16473 3/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21801377 0.95 CYP1A2 (0.38) MAPTCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL24345188 0.91 MAPT (0.43) MAPTCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL21801365 0.90 MAPT (0.41) MAPTCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL24490646 0.88 CYP1A2 (0.40) MAPTCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL21801583 0.86 MAPT (0.40) MAPTCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL24345334 0.86 CYP1A2 (0.41) MAPTCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL21801374 0.85 CYP1A2 (0.38) MAPTCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL28650199 0.82 CYP1A2 (0.38) MAPTCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL21178737 0.81 RET (0.48) MAPTCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL21801401 0.81 RET (0.37) HSD17B10RETTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3849986-A1 FUSED HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS Array Biopharma, Inc. (US) 2021-07-21 — — EP disclosed
WO-2020055672-A1 FUSED HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2020-03-19 — — WO disclosed
Send feedback